The antibody secukinumab blocks a key protein believed to cause the inflammatory skin disease
ADRIANA BARTON, The Globe and Mail
Tue, 07/29/2014 - 1:25pm
The antibody secukinumab blocks a key protein believed to cause the inflammatory skin disease